Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Total Debt (2016 - 2025)

Conmed's Total Debt history spans 16 years, with the latest figure at $834.9 million for Q4 2025.

  • For Q4 2025, Total Debt fell 7.82% year-over-year to $834.9 million; the TTM value through Dec 2025 reached $834.9 million, down 7.82%, while the annual FY2025 figure was $834.9 million, 7.82% down from the prior year.
  • Total Debt reached $834.9 million in Q4 2025 per CNMD's latest filing, down from $853.8 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $1.1 billion in Q1 2023 to a low of $684.7 million in Q4 2021.
  • Average Total Debt over 5 years is $901.2 million, with a median of $923.3 million recorded in 2024.
  • Peak YoY movement for Total Debt: skyrocketed 54.07% in 2022, then decreased 9.96% in 2025.
  • A 5-year view of Total Debt shows it stood at $684.7 million in 2021, then surged by 54.07% to $1.1 billion in 2022, then dropped by 7.68% to $973.8 million in 2023, then dropped by 6.99% to $905.8 million in 2024, then decreased by 7.82% to $834.9 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Total Debt are $834.9 million (Q4 2025), $853.8 million (Q3 2025), and $881.8 million (Q2 2025).